Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, vol.7, no.4, pp.191-196, 2010 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 7 Issue: 4
- Publication Date: 2010
- Doi Number: 10.7150/ijms.7.191
- Journal Name: INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.191-196
- Keywords: coronary artery disease, drug-eluting stent, major adverse cardiac event, stent thrombosis, RANDOMIZED CONTROLLED-TRIAL, T-SEARCH, METAANALYSIS, IMPLANTATION, ANGIOPLASTY, RESTENOSIS, PREVENTION, THROMBOSIS
- Open Archive Collection: AVESIS Open Access Collection
- Akdeniz University Affiliated: Yes
Abstract
Background: The efficacy of drug-eluting stents has been shown in randomized trials, but some controversy exists regarding which stent sirolimus-eluting or paclitaxel-eluting is more effective in unselected Turkish patients. Therefore, we investigated the clinical outcomes of patients who were treated with one type of these drug-eluting stents in the real world.